Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR   US00484M1062

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/24/2014 10/27/2014 10/28/2014 10/29/2014 10/30/2014 Date
34.25(c) 34.46(c) 35.06(c) 35.88(c) 36.15(c) Last
407 618 452 108 635 823 956 107 821 505 Volume
-2.23% +0.61% +1.74% +2.34% +0.75% Change
More quotes
Company
Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system.The company's two main products are Ampyra and Zanaflex... 
Sector
Biotechnology & Medical Research
Calendar
10/30 | 08:30amEarnings Call
Surperformance© rating of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More about the company
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 370 M
EBIT 2014 25,3 M
Net income 2014 7,60 M
Debt 2014 -
Yield 2014 -
Sales 2015 403 M
EBIT 2015 14,5 M
Net income 2015 12,7 M
Debt 2015 -
Yield 2015 -
PER 2014 147,72
PER 2015 178,15
Capi. / Sales 2014 4,05x
Capi. / Sales 2015 3,72x
Capitalization 1 498 M
More Financials
Latest news on ACORDA THERAPEUTICS INC
1d ago ACORDA THERAPEUTICS : tops 3Q revenue forecasts
1d ago ACORDA THERAPEUTICS : Results of Operations and Financial Condition, Financial S..
1d ago ACORDA THERAPEUTICS : CORRECTING and REPLACING Acorda Therapeutics Reports Third..
2d ago ACORDA THERAPEUTICS : Completes Acquisition of Civitas Therapeutics
4d ago ACORDA THERAPEUTICS : Acquires Civitas Therapeutics
7d ago ACORDA THERAPEUTICS : Completion of Acquisition or Disposition of Assets, Financ..
10/23 ACORDA THERAPEUTICS : to Host Conference Call to Discuss Third Quarter 2014 Fina..
10/22 ACORDA THERAPEUTICS : Completes Acquisition of Civitas Therapeutics
10/15 ACORDA THERAPEUTICS : Patent Issued for Compositions and Methods of Using Chondr..
10/14 ACORDA THERAPEUTICS : Assigned Patent
10/08 UK cost agency rejects British company GW's cannabis drug
10/02 REGENERON PHARMACEUTICALS : Biotech companies announce earnings boosts
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF